CSI Market
Sign In | Register

Lipella Pharmaceuticals Inc (LIPO) Annual Balance Sheets

Annual · GAAP · USD millions
Access LIPO quarterly Balance Sheets →
The balance sheet figures below highlight longer-term patterns in how Lipella Pharmaceuticals Inc finances operations and invests in assets.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2024)
(Dec 31 2023) (Dec 31 2022)
Assets
Cash & cash equivalent2.18
Cash & Short-term Investments2.00
Accounts receivable0.08
Prepaid Expense, Current AS0.35
Total Current Assets2.62
Equipment/Property/Plant Net0.01
Other Assets, Noncurrent0.05
Operating Lease Right Of Use Asset0.05
Total Assets2.67
Liabilities
Accounts Payable, Current AC0.39
Accrued Liabilities, Current AC0.24
Notes Payable, Current NO0.00
Other Liabilities, Current0.00
Total Current Liabilities0.75
Total Long-term Debt0.00
Other liabilities, Noncurrent0.00
Operating Lease Liability Current0.05
Payroll Liability0.08
Related Party Interest-
Operating Lease Liability Noncurrent-
Total Liabilities0.75
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock17.26
Retained Earnings / Accumulated Deficit-15.34
Other Equity0.00
Common Stockholder's Equity1.92
Preferred Stockholder's Equity0.00
Total Stockholder's Equity1.92
Liabilities & Stockholder's Equity2.67
4 historic quarters locked

Sign in to unlock the full Lipella Pharmaceuticals Inc balance sheet history.

Sign In Create Free Account

About Lipella Pharmaceuticals Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20241231)
  • Filed with the SEC: March 27, 2025
  • Source: g084734_10k.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001753926-25-000507

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License